Shaping better health
REMEDY : BNSSG referral pathways & Joint Formulary


Home > Adults > Diabetes >

Monogenic Diabetes

Checked: 21-06-2023 by 5 Rob Adams Next Review: 21-06-2025

Overview

Please note: Patients with suspected new onset Type 1 Diabetes should be referred via the Rapid Access Clinic

Monogenic diabetes is an inherited type of diabetes where a pathogenic variant in a single gene causes diabetes. It affects about 2-5% of people with diabetes, and many of these patients are often incorrectly diagnosed as having type 1 or type 2 diabetes (1).

The subtypes of monogenic diabetes most commonly diagnosed in the UK have an autosomal dominant pattern of inheritance where first-degree relatives have a 50% chance of inheriting the variant and being affected. Monogenic diabetes can be broadly split into three categories:

  • Neonatal diabetes diagnosed under 6 months of age.
  • MODY (Maturity onset diabetes of the young) characterised by non-syndromic diabetes without features of autoimmunity or insulin resistance that typically presents between the ages of 10 and 30 years.
  • Syndromic diabetes that can be diagnosed in neonatal, paediatric or early adult ages and is characterised by diabetes and additional extra-pancreatic features (e.g. deafness, neurological problems, structural renal disease) as part of a genetic syndrome.

The severity of monogenic diabetes is variable and it can be associated with other problems, e.g. with kidneys or liver, deafness, increased risk of early IHD etc. 

Who to Refer

Enquire about family history, including whether diabetes was diagnosed incidentally in other family members and their HbA1c levels if known.

Enter details into the MODY probability calculator ( link provided by Exeter Diabetes App):

The calculator gives a risk score and appropriate next steps. Consider referring for testing where probability is >20%.

A number of key features make a diagnosis of monogenic diabetes more likely:

  • Young age of onset; typically before the age of 35 years or diagnosed in the first 6 months of life
  • A less severe diabetes presentation with absence of ketoacidosis and HbA1c <58mmol/mol (7.5%) at diagnosis
  • Diabetes identified in two or more generations
  • A normal BMI and absence of features associated with metabolic syndrome
  • Absence of islet-autoantibodies
  • Not insulin dependent (not insulin treated or C-peptide is detectable outside of the usual honeymoon period)
  • Asymptomatic persistent fasting hyperglycaemia and stable but mildly raised HbA1c that does not change with treatment
  • History of newborn macrosomia and neonatal hypoglycaemia in the family
  • Sensitivity to sulphonylureas (low doses result in significant improvement in control or hypoglycaemia)
  • Additional developmental problems suggestive of a genetic syndrome.

What to do before referral

Before referral for genetic testing for monogenic diabetes, consider the eligibility criteria below:

Please note that genetic testing for monogenic diabetes will only be performed on patients confirmed to have diabetes by laboratory blood glucose or HbA1c.

Referral

Genetic Testing

The Exeter Genomics Laboratory at the Royal Devon & Exeter Hospital is the national specialist provider for all monogenic diabetes testing in England.

Requests for testing from GPs are accepted and do not require referral to clinical genetics or a secondary care consultant since the laboratory will determine suitability for testing and provide guidance if a genetic diagnosis is made. Testing is centrally funded by NHSE for patients meeting eligibility criteria; there is no charge to the GP or ICB.

Collect 3-5ml of EDTA whole blood and send with both of the following forms: MODY request form and Bristol Genomics request form:

The sample can be picked up with other routine blood tests from the practice and once received by the lab it will be forwarded to the Bristol Genomics Laboratory for processing.

Family Testing if Result is Positive

If molecular genetic testing confirms a diagnosis of monogenic diabetes, arrange genetic testing for other family members with a diabetes diagnosis as this may alter their treatment. The Exeter Genomics Laboratory can provide assistance with this through provision of ‘at-home’ self-collection kits for capillary blood; contact rduh.betacellgenomics@nhs.net for details.

First degree relatives not known to have diabetes can be offered pre-symptomatic testing but this requires genetic counselling so the individual can decide whether or not to proceed. 

Alert! There are different implications for testing family members depending on the gene affected so specialist advice should be sought from the Exeter team: m.shepherd1@nhs.net

Resources

 

 

 



Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.